Kaustav Chowdhury

Kaustav Chowdhury

Auto-generated profile, based on publicly available information

Kaustav Chowdhury

Department of Rheumatology, All India Institute of Medical Science, Delhi, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
GKGausal A Khan
Gausal A Khan
MHMashael Huwaikem
Mashael Huwaikem
KCKaustav Chowdhury
Kaustav Chowdhury
HAHumood Fahm Albugami
Humood Fahm Albugami
AGArjun Ghosh
Arjun Ghosh
Sterile inflammation (SI) is an inflammatory response triggered by the release of damage‐associated molecular patterns (DAMPs) from dying cells, distinct from normal inflammation in its origin from tissue injury and necrosis rather than microbial invasion. Circulating nucleic acids (CNAs), high‐mobility group box 1 (HMGB1), von Willebrand factor (vWF), and S100b protein are notable markers of SI, indicative of tissue damage and implicated in thrombotic disorders. Innate immunity, involving cells like macrophages and dendritic cells, recognizes DAMPs via pattern recognition receptors (PRRs) like Toll‐like receptors and NOD‐like receptors, initiating inflammatory signaling cascades central to SI and its cardiovascular consequences. Thrombosis, a common outcome of SI, underscores the intricate interplay between inflammation and hemostasis, with hypoxia exacerbating thrombotic risk through platelet activation and endothelial dysfunction. The established link between inflammation and thrombosis highlights the clinical significance of SI, where molecules like HMGB1, extracellular RNA (eRNA), and eDNA actively participate in thromboembolic disorders. SI’s relevance is particularly evident in COVID‐19‐induced thrombotic disorders, where dysregulated immune responses and endothelial dysfunction contribute to systemic inflammation and heightened thrombotic risk. Understanding SI’s mechanisms in these contexts is vital for developing targeted therapies to mitigate vascular complications and enhance patient outcomes in cardiovascular diseases and COVID‐19‐associated thrombosis.